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A B S T R A C T
Most cases of recurrent hypoglycemia occur in patients with diabetes mellitus and can be prevented by
changes in medications, diet or activity. However, a person with unexplained hypoglycemia can indi-
cate potentially grave, often treatable underlying disorders such as insulinoma, Addison’s disease or
hypopituitarism. Medication is another cause of unexplained hypoglycemia. A focused laboratory work-
up is essential, often a plasma/serum glucose, insulin and C-peptide. Normal or high insulin and C-peptide
levels indicate excessive endogenous insulin production. We are reporting a case of Insulin Autoim-
mune Syndrome (IAS) in a 38-year-old Indian female who presented to us with recurrent episodes of
spontaneous hypoglycemia. On evaluation, the patient was found to have Endogenous Hyperinsulinemic
Hypoglycemia (EHH). As no obvious cause of EHH was found on abdominal imaging, we further evalu-
ated her for insulin antibodies which were found to be raised. A diagnosis of IAS was made and the patient
was put on a diet of frequent small meals and she improved. Most cases of this syndrome have been
reported from Japan and very few case reports of IAS exist in India. Thus IAS, though rare, should be kept
in the differential diagnosis of spontaneous hypoglycemia.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Insulin Autoimmune Syndrome (IAS), also known as Hirata’s
disease, is a rare cause of hypoglycemia and is characterized by epi-
sodes of spontaneous hypoglycemia and insulin autoantibodies in
the individuals who have not received exogenous insulin [1]. It was
ﬁrst reported by Hirata et al. in 1970 and is the third most common
cause of hypoglycemia in Japan, where more than 300 cases of this
syndrome have been reported [2].
IAS has association with other autoimmune diseases like Graves’
disease and rheumatoid arthritis and association with HLA DR4 has
been demonstrated in 96% of Japanese patients with IAS [3].
Exact mechanism of hypoglycemia in IAS is unclear but inter-
action of sulfhydryl groupwith disulﬁde bond in the insulinmolecule
has been postulated to play a role [4]. Methimazole is the most com-
monly associated prescribedmedicine, others being D-penicillamine,
procainamide, isoniazid, hydralazine, glutathione, captopril and
imipenem. A few case reports of IAS associated with use of Alpha
Lipoic Acid (ALA) exist in the literature [5–7].
Very few case reports of this syndrome exist in India, ﬁrst re-
portedcasebeing in2013 [8–10]. It is important tokeep this syndrome
in the differential diagnosis of Endogenous Hyperinsulinemic Hy-
poglycemia (EHH) so that early recognition can be done and
unnecessary investigations can be avoided.
Case report
We report a case of 38-year-old Indian female, who was referred
to our Endocrine Outpatient Clinic for evaluation of frequent hypo-
glycemia. She was non-diabetic, non-hypertensive, not on any
medications, presentedwith chief complaints of weight gain of 4 kg
over thepast onemonth, 5–6 episodes of hypoglycemia and1episode
of unconsciousness. There was no history of any prior exposure to
insulin or any oral antidiabeticmedication. Her symptomsbegan one
monthbackwhensheused todevelopepisodesof palpitations, sweat-
ing, tremors and anxiety, which were relieved on ingestion of food.
Twenty days after her symptoms began, she had one episode of un-
consciousness for which she was taken to a local hospital where her
random plasma glucose was found to be 25mg/dl and she regained
consciousness on administration of intravenous 25% dextrose
* Corresponding author. Faculty of Medicine, J.N. Medical College, Rajiv Gandhi
Centre for Diabetes and Endocrinology, Aligarh Muslim University, Aligarh 202002,
India. Tel.: 0091 9412459552.
E-mail address: jamalahmad11@rediffmail.com (J. Ahmad).
2214-6245/© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
http://dx.doi.org/10.1016/j.jecr.2016.05.003
Journal of Clinical and Translational Endocrinology: Case Reports 2 (2016) 7–9
Contents lists available at ScienceDirect
Journal of Clinical and Translational Endocrinology:
Case Reports
journal homepage: www.elsevier.com/ locate / jecr
infusion. She was admitted in Endocrine ward for further evalua-
tion.Generalphysical examination revealedanobese, alert andhealthy
female. Her weight was 70 kg, height 143 cm, BMI 34.2, blood pres-
sure 122/80mmHg and pulse rate was 74/min. Her renal function,
liver function tests, thyroid proﬁle and hemogramwere found to be
normal. Tests for anti-thyroid antibodies, rheumatoid factor and an-
tinuclear antibodies were found to be negative. Serum sulfonylurea
screen was done and found to be negative. Her HbA1c was 5.4%. On
admission, she underwent 72-hour fast test but she did not develop
hypoglycemia. However, she developed spontaneous hypoglycemia
in the post-absorptive state when her plasma glucose concentration
was found to be 40 mg/dl and corresponding serum insulin was
>600 μIU/ml and C-peptidewas 5.66 ng/ml. Insulin levelsweremea-
sured by electrochemiluminescence immunoassay (ECLIA) method
(Roche). Onadmission, a provisional diagnosis of insulinomawaskept
and her abdominal ultrasound was normal except for mild hepato-
megaly. Contrast enhanced CT scan of upper abdomen (triple phase)
did not reveal any mass lesion. An extended 75 g oral glucose toler-
ance test was performed which revealed a basal value of 78mg/dl
with peak at 1 hour of 148mg/dl and lowest at 4 hour with a value
of 38mg/dl, with corresponding insulin value of >600 μIU/ml.
Serum insulin antibodies were measured by enzyme immuno-
assay (EIA) and were found to be 47.44 U/ml and diagnosis of IAS
was made. She was kept on a diet of frequent small meals and her
symptoms gradually disappeared. Notably, our patient was not found
to have any autoimmune disease nor was she giving history of intake
of any medication. On 2 months follow-up, she has not developed
any episode of hypoglycemia again and has improved on dietary
modiﬁcation only.
Discussion
Here, we report a case of Insulin Autoimmune Syndrome
which was suspected in our patient as she had very high serum
insulin levels in association with hypoglycemia. Endogenous
Hyperinsulinemic Hypoglycemia (EHH) is characterized by exces-
sive production of endogenous insulin resulting in low blood sugar.
The commonest cause of EHH is insulinoma. IAS is a rare cause of
EHH, and very few cases have been reported worldwide. Majority
of cases have been reported from Japan and although rare in non-
Asian populations, a few cases have been reported in Caucasian
population [11–14]. It may be associated with underlying autoim-
mune disorders like Graves’ disease, systemic lupus erythematosus,
systemic sclerosis and rheumatoid arthritis [3,15].
Hypoglycemia occurring in IAS is probably due to dissociation of
insulin from its antibodies in the post-absorptive state. In our patient,
72-hour fast test did not cause hypoglycemia but it occurred spon-
taneously in thepost-absorptive state4–6hours aftermeal. Thewidely
accepted hypothesis for themechanism of hypoglycemia in patients
with IAS is that there is a mismatch between free insulin concen-
tration and blood glucose due to insulin autoantibodies, which bind
the hormone and release it later [16]. Extremely high levels of insulin
(>600 μIU/mL) found in our patient also favored a diagnosis of IAS.
Woo CY et al. in their retrospective analyses of 84 patients with EHH
from1998 to2012presenting inaUniversityHospital inKorea showed
that median insulin values were 14.1 μIU/mL in patients with
insulinoma and >1000 μIU/mL in patients with IAS [17]. In patients
of insulinoma, serum insulin levels are seldom more than 100 μIU/
mL [18]. This magnitude of insulin elevation found in IAS can be
explainedbydelayed clearanceof insulinbecauseof bindingof insulin
to autoantibodies [19]. Woo CY et al. also showed that in their anal-
yses, all 74 patients of insulinoma developed hypoglycemia on
continued fasting, however, only 3 out of 7 non-insulinoma patients
did so [17]. Similar ﬁndings were seen in our patient who did not
develop hypoglycemia on 72-hour fast test, which can be taken as
another clue to the diagnosis of IAS. Wang YL in their analyses of 73
cases of IAS in China demonstrated a peak incidence in the age group
of 60–69 years for males and 30–39 years for females. Sex differ-
ences were not found except in the age group of 30–39 years where
majoritywere found to be females [15]. Our patient diagnosed as IAS
wasa38-year-old female. She improvedondietarymanagementalone
consisting of frequent small meals. Acarbose has been used in the
treatmentof IASas it decreasesglucoseabsorptionbut itsuse is limited
due to gastrointestinal side effects like bloating and diarrhea. Corti-
costeroids may be used in refractory cases [14]. Insulin antibodies
decline gradually in many cases but the patients should be kept on
a regular follow-up [20]. Our patient is on regular follow-up until the
date she has been asymptomatic.
Conclusion
IAS is a rare cause of endogenous hyperinsulinemic hypoglyce-
mia, but it should be suspected in patients whom there is failure
to localize an abdominal tumor and who demonstrate extremely
high insulin levels. As IAS mostly runs a benign course, unneces-
sary investigations and surgical procedures could be avoided. Insulin
autoantibodies should be tested in such patients in whom there is
high index of suspicion. Thus IAS, though a rare cause of hypogly-
cemia, should not be forgotten.
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